Is adjunctive systemic chemotherapy after cystectomy for T2N+ disease of therapeutic benefit?

Matthew D. Galsky, Scott T. Tagawa, Shahrokh F. Shariat

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Original language	English
Pages (from-to)	358-360
Number of pages	3
Journal	Journal of Urology
Volume	188
Issue number	2
DOIs	https://doi.org/10.1016/j.juro.2012.05.026
State	Published - Aug 2012

Access to Document

10.1016/j.juro.2012.05.026

Cite this

@article{05e374e229de4025a5e9a95393447d16,

title = "Is adjunctive systemic chemotherapy after cystectomy for T2N+ disease of therapeutic benefit?",

author = "Galsky, {Matthew D.} and Tagawa, {Scott T.} and Shariat, {Shahrokh F.}",

year = "2012",

month = aug,

doi = "10.1016/j.juro.2012.05.026",

language = "English",

volume = "188",

pages = "358--360",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "2",

}

TY - JOUR

T1 - Is adjunctive systemic chemotherapy after cystectomy for T2N+ disease of therapeutic benefit?

AU - Galsky, Matthew D.

AU - Tagawa, Scott T.

AU - Shariat, Shahrokh F.

PY - 2012/8

Y1 - 2012/8

UR - http://www.scopus.com/inward/record.url?scp=84863720130&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2012.05.026

DO - 10.1016/j.juro.2012.05.026

M3 - Comment/debate

C2 - 22704119

AN - SCOPUS:84863720130

SN - 0022-5347

VL - 188

SP - 358

EP - 360

JO - Journal of Urology

JF - Journal of Urology

IS - 2

ER -